← FDA DRUG APPROVALS

FDA ANDA · ANDA077487

FAMCICLOVIR

Sponsor: TEVA PHARMS

APPLICATION
ANDA077487
TYPE
ANDA
ORIGINAL APPROVAL
2007-08-24
LATEST ACTION
2019-07-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

FAMCICLOVIRPrescription
FAMCICLOVIR 500MG · TABLET · ORAL
FAMCICLOVIRPrescription
FAMCICLOVIR 125MG · TABLET · ORAL
FAMCICLOVIRPrescription
FAMCICLOVIR 250MG · TABLET · ORAL

Approval history

2019-07-08Labeling · Supplement 9 · standardAP
2013-06-27Labeling · Supplement 7 · standardAP
2011-07-29Labeling · Supplement 5AP
2011-05-09Labeling · Supplement 4AP
2009-04-29Labeling · Supplement 3AP
2007-08-24OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →